Treatment Indications for Antidepressants Prescribed in Primary Care in Quebec, Canada, 2006-2015 | Anxiety Disorders | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.204.227.34. Please contact the publisher to request reinstatement.
1.
National Center for Health Statistics.  Health, United States, 2010 with special feature on death and dying. http://www.cdc.gov/nchs/data/hus/hus10.pdf. Accessed July 23, 2015.
2.
Gardarsdottir  H, Heerdink  ER, van Dijk  L, Egberts  ACG.  Indications for antidepressant drug prescribing in general practice in the Netherlands.  J Affect Disord. 2007;98(1-2):109-115. PubMedGoogle ScholarCrossref
3.
Tamblyn  R, Huang  A, Kawasumi  Y,  et al.  The development and evaluation of an integrated electronic prescribing and drug management system for primary care.  J Am Med Inform Assoc. 2006;13(2):148-159. PubMedGoogle ScholarCrossref
4.
Bartlett  G, Tamblyn  R, Kawasumi  Y, Poissant  L, Taylor  L.  Nonparticipation bias in health services research using data from an integrated electronic prescribing project: the role of informed consent.  Acta Bioeth. 2005;11(2):145-159. http://www.scielo.cl/pdf/abioeth/v11n2/art05.pdf.Google ScholarCrossref
5.
Eguale  T, Winslade  N, Hanley  JA, Buckeridge  DL, Tamblyn  R.  Enhancing pharmacosurveillance with systematic collection of treatment indication in electronic prescribing: a validation study in Canada.  Drug Saf. 2010;33(7):559-567. PubMedGoogle ScholarCrossref
6.
Carey  V, Zeger  SL, Diggle  P.  Modelling multivariate binary data with alternating logistic regressions.  Biometrika. 1993;80(3):517-526. doi:10.2307/2337173.Google ScholarCrossref
Research Letter
May 24/31, 2016

Treatment Indications for Antidepressants Prescribed in Primary Care in Quebec, Canada, 2006-2015

Author Affiliations
  • 1Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada
  • 2School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston
JAMA. 2016;315(20):2230-2232. doi:10.1001/jama.2016.3445

Antidepressant use in the United States has increased over the last 2 decades.1 A suspected reason for this trend is that primary care physicians are increasingly prescribing antidepressants for nondepressive indications, including unapproved (off-label) indications that have not been evaluated by regulatory agencies.2 However, the frequency with which physicians prescribe antidepressants for nondepressive indications is unknown because treatment indications are rarely documented. We analyzed the prevalence of treatment indications for antidepressants and assessed temporal trends in antidepressant prescribing for depression.

This study used data from the Medical Office of the 21st Century (MOXXI) research platform.3 MOXXI is an electronic medical record (EMR) and prescribing system that has been used by primary care physicians in community-based, fee-for-service practices around 2 major urban centers in Quebec, Canada. During the study period, approximately 185 physicians (25% of eligible) and 100 000 patients (30% of all who visited a MOXXI physician) gave informed consent to use the EMR and have their information used for research purposes. Compared with nonconsenters, MOXXI physicians were younger and MOXXI patients were older with more health complexities.4

×